The direct evidence and mechanism of traditional Chinese medicine treatment of COVID-19
出版年份 2021 全文链接
标题
The direct evidence and mechanism of traditional Chinese medicine treatment of COVID-19
作者
关键词
SARS-CoV-2, COVID-19, Traditional Chinese medicine, Direct evidence, Efficacy advantage, Mechanism
出版物
BIOMEDICINE & PHARMACOTHERAPY
Volume 137, Issue -, Pages 111267
出版商
Elsevier BV
发表日期
2021-01-15
DOI
10.1016/j.biopha.2021.111267
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
- (2020) Ning Tang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- COVID-19 and the cardiovascular system
- (2020) Ying-Ying Zheng et al. Nature Reviews Cardiology
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2
- (2020) Renhong Yan et al. SCIENCE
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- On the origin and continuing evolution of SARS-CoV-2
- (2020) Xiaolu Tang et al. National Science Review
- Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
- (2020) Michael Letko et al. Nature Microbiology
- Evaluation of the Adjuvant Efficacy of Natural Herbal Medicine on COVID-19: A Retrospective Matched Case-Control Study
- (2020) Hai-Tao Zhang et al. AMERICAN JOURNAL OF CHINESE MEDICINE
- Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2
- (2020) Guoshuai Cai et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Transcriptional suppression of androgen receptor by 18β-glycyrrhetinic acid in LNCaP human prostate cancer cells
- (2020) You Sun et al. ARCHIVES OF PHARMACAL RESEARCH
- Protection against COVID-19 injury by Qingfei Paidu decoction via anti-viral, anti-inflammatory activity and metabolic programming
- (2020) Jian Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
- (2020) Evangelos J. Giamarellos-Bourboulis et al. Cell Host & Microbe
- Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome
- (2020) Nicholas S. Hendren et al. CIRCULATION
- Will Complement Inhibition Be the New Target in Treating COVID-19–Related Systemic Thrombosis?
- (2020) Courtney M. Campbell et al. CIRCULATION
- Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
- (2020) Chuan Qin et al. CLINICAL INFECTIOUS DISEASES
- Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis
- (2020) Gaurav Aggarwal et al. CURRENT PROBLEMS IN CARDIOLOGY
- Diabetes is a risk factor for the progression and prognosis of COVID-19
- (2020) Weina Guo et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy
- (2020) Angela Ceribelli et al. JOURNAL OF AUTOIMMUNITY
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Immunoregulation with mTOR inhibitors to prevent COVID‐19 severity: A novel intervention strategy beyond vaccines and specific antiviral medicines
- (2020) Yunfeng Zheng et al. JOURNAL OF MEDICAL VIROLOGY
- ISTH interim guidance on recognition and management of coagulopathy in COVID‐19
- (2020) Jecko Thachil et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Coronavirus Endoribonuclease and Deubiquitinating Interferon Antagonists Differentially Modulate the Host Response during Replication in Macrophages
- (2020) Aaron Volk et al. JOURNAL OF VIROLOGY
- COVID-19: the case for health-care worker screening to prevent hospital transmission
- (2020) James R M Black et al. LANCET
- Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
- (2020) Nicole M Kuderer et al. LANCET
- Endothelial cell infection and endotheliitis in COVID-19
- (2020) Zsuzsanna Varga et al. LANCET
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Profile of a killer: the complex biology powering the coronavirus pandemic
- (2020) David Cyranoski NATURE
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
- (2020) Waradon Sungnak et al. NATURE MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
- (2020) Muthiah Vaduganathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Compassionate Use of Remdesivir for Patients with Severe Covid-19
- (2020) Jonathan Grein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial
- (2020) Ke Hu et al. PHYTOMEDICINE
- Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors
- (2020) Matthew Hackbart et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cell entry mechanisms of SARS-CoV-2
- (2020) Jian Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection
- (2020) Xin Zou et al. Frontiers of Medicine
- Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China
- (2020) Shaobo Shi et al. JAMA Cardiology
- Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients
- (2020) Jing Liu et al. EBioMedicine
- Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis
- (2020) Ren Mao et al. Lancet Gastroenterology & Hepatology
- Network pharmacology-based analysis of the role of traditional Chinese herbal medicines in the treatment of COVID-19
- (2020) Shengwei Yu et al. Annals of Palliative Medicine
- Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients
- (2020) Hai-xia Su et al. ACTA PHARMACOLOGICA SINICA
- Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids
- (2020) Amene Saghazadeh et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
- (2020) W. Joost Wiersinga et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Identifying potential treatments of COVID-19 from Traditional Chinese Medicine (TCM) by using a data-driven approach
- (2020) Xia Ren et al. JOURNAL OF ETHNOPHARMACOLOGY
- Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway
- (2020) Qinhai Ma et al. PHARMACOLOGICAL RESEARCH
- Chemical composition and pharmacological mechanism of Qingfei Paidu Decoction and Ma Xing Shi Gan Decoction against Coronavirus Disease 2019 (COVID-19): In silico and experimental study
- (2020) Ruocong Yang et al. PHARMACOLOGICAL RESEARCH
- Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: A randomized controlled trial
- (2020) Mingzhong Xiao et al. PHARMACOLOGICAL RESEARCH
- Hanshiyi Formula, an approved medicine for Sars-CoV2 infection in China, reduced the proportion of mild and moderate COVID-19 patients turning to severe status: A cohort study
- (2020) Jiaxing Tian et al. PHARMACOLOGICAL RESEARCH
- Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)
- (2020) Li Runfeng et al. PHARMACOLOGICAL RESEARCH
- Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility
- (2020) Hong-Long Ji et al. PHYSIOLOGICAL REVIEWS
- Contribution of traditional Chinese medicine to the treatment of COVID-19
- (2020) Wan-Ying Wang et al. PHYTOMEDICINE
- The implications of silent transmission for the control of COVID-19 outbreaks
- (2020) Seyed M. Moghadas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanism of Dayuanyin in the treatment of coronavirus disease 2019 based on network pharmacology and molecular docking
- (2020) Xiaofeng Ruan et al. Chinese Medicine
- Potential mechanism prediction of Cold-Damp Plague Formula against COVID-19 via network pharmacology analysis and molecular docking
- (2020) Lin Han et al. Chinese Medicine
- International traditional Chinese medicine guideline for diagnostic and treatment principles of diabetes
- (2020) Fengmei Lian et al. Annals of Palliative Medicine
- Active constituents and mechanisms of Respiratory Detox Shot, a traditional Chinese medicine prescription, for COVID-19 control and prevention: Network-molecular docking-LC–MSE analysis
- (2020) Zi-jia Zhang et al. Journal of Integrative Medicine-JIM
- Efficacy of herbal medicine (Xuanfei Baidu decoction) combined with conventional drug in treating COVID-19:A pilot randomized clinical trial
- (2020) Wu-zhong Xiong et al. Integrative Medicine Research
- COVID-19 Vaccine Frontrunners and Their Nanotechnology Design
- (2020) Young Hun Chung et al. ACS Nano
- Immunopathology of Hyperinflammation in COVID-19
- (2020) Joshua N. Gustine et al. AMERICAN JOURNAL OF PATHOLOGY
- Yidu-toxicity blocking lung decoction ameliorates inflammation in severe pneumonia of SARS-COV-2 patients with Yidu-toxicity blocking lung syndrome by eliminating IL-6 and TNF-a
- (2020) Jie Zhao et al. BIOMEDICINE & PHARMACOTHERAPY
- Clinical retrospective study on the efficacy of Qingfei Paidu decoction combined with Western medicine for COVID-19 treatment
- (2020) Siyi Xin et al. BIOMEDICINE & PHARMACOTHERAPY
- Innate immunity during SARS‐CoV‐2: evasion strategies and activation trigger hypoxia and vascular damage
- (2020) S. Amor et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Long-term infection of SARS-CoV-2 changed the body's immune status
- (2020) Lan Lin et al. CLINICAL IMMUNOLOGY
- Emergence of genomic diversity and recurrent mutations in SARS-CoV-2
- (2020) Lucy van Dorp et al. INFECTION GENETICS AND EVOLUTION
- Chinese herbal medicine reduces mortality in patients with severe and critical Coronavirus disease 2019: a retrospective cohort study
- (2020) Guohua Chen et al. Frontiers of Medicine
- A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench study
- (2020) Keng-Chang Tsai et al. BIOMEDICINE & PHARMACOTHERAPY
- Covid-19: UK approves Oxford vaccine as cases of new variant surge
- (2020) Elisabeth Mahase BMJ-British Medical Journal
- Deciphering the Pharmacological Mechanisms of Ma Xing Shi Gan Decoction against COVID-19 through Integrating Network Pharmacology and Experimental Exploration
- (2020) Qianqian Li et al. Frontiers in Pharmacology
- The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020
- (2020) Sara E. Oliver et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Contemporary Diagnosis and Management of Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease: A Scientific Statement From the American Heart Association
- (2019) Jacqueline E. Tamis-Holland et al. CIRCULATION
- The clinical significance of interleukin‐6 in heart failure: results from the BIOSTAT‐CHF study
- (2019) George Markousis‐Mavrogenis et al. EUROPEAN JOURNAL OF HEART FAILURE
- Coronavirus envelope protein: current knowledge
- (2019) Dewald Schoeman et al. Virology Journal
- Diagnosis and management of sepsis‐induced coagulopathy and disseminated intravascular coagulation
- (2019) Toshiaki Iba et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Quercetin supports cell viability and inhibits apoptosis in cardiocytes by down-regulating miR-199a
- (2019) Gongliang Guo et al. Artificial Cells Nanomedicine and Biotechnology
- Toxicokinetics of hydroxychloroquine following a massive overdose
- (2019) Jonathan de Olano et al. AMERICAN JOURNAL OF EMERGENCY MEDICINE
- The stimulation of thrombosis by hypoxia
- (2019) Neha Gupta et al. THROMBOSIS RESEARCH
- Viral metagenomics, protein structure, and reverse genetics: Key strategies for investigating coronaviruses
- (2018) Bryan A. Johnson et al. VIROLOGY
- RNA Virus Fidelity Mutants: A Useful Tool for Evolutionary Biology or a Complex Challenge?
- (2018) Tiffany Kautz et al. Viruses-Basel
- The Immunomodulatory and Anti-Inflammatory Role of Polyphenols
- (2018) Nour Yahfoufi et al. Nutrients
- Traditional Chinese Medicine for Cardiovascular Disease
- (2017) Panpan Hao et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The not-so-infinite malleability of RNA viruses: Viral and cellular determinants of RNA virus mutation rates
- (2017) Everett Clinton Smith PLoS Pathogens
- Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection
- (2017) Qi Wu et al. Scientific Reports
- Immunotherapeutic implications of IL-6 blockade for cytokine storm
- (2016) Toshio Tanaka et al. Immunotherapy
- Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: Role of epigenetic histone modifications
- (2015) Kulbhushan Tikoo et al. BIOCHEMICAL PHARMACOLOGY
- Activation of the GLP-1 Receptor by Liraglutide Increases ACE2 Expression, Reversing Right Ventricle Hypertrophy, and Improving the Production of SP-A and SP-B in the Lungs of Type 1 Diabetes Rats
- (2015) Marina Romaní-Pérez et al. ENDOCRINOLOGY
- IL-6 as a keystone cytokine in health and disease
- (2015) Christopher A Hunter et al. NATURE IMMUNOLOGY
- Erratum: Traditional Chinese medication for cardiovascular disease
- (2015) Pan-Pan Hao et al. Nature Reviews Cardiology
- Coronavirus envelope (E) protein remains at the site of assembly
- (2015) Pavithra Venkatagopalan et al. VIROLOGY
- Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula
- (2014) Jia Xu et al. ISME Journal
- Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus
- (2014) Anna Lundin et al. PLoS Pathogens
- SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex
- (2014) Xiaojuan Chen et al. Protein & Cell
- Roles of Inflammation, Oxidative Stress, and Vascular Dysfunction in Hypertension
- (2014) Quynh N. Dinh et al. Biomed Research International
- Oseltamivir Compared With the Chinese Traditional Therapy Maxingshigan–Yinqiaosan in the Treatment of H1N1 Influenza
- (2013) Chen Wang et al. ANNALS OF INTERNAL MEDICINE
- SARS-CoV ORF1b-encoded nonstructural proteins 12–16: Replicative enzymes as antiviral targets
- (2013) Lorenzo Subissi et al. ANTIVIRAL RESEARCH
- Connecting Type 1 and Type 2 Diabetes through Innate Immunity
- (2013) J. I. Odegaard et al. Cold Spring Harbor Perspectives in Medicine
- Diarylheptanoids from Alnus japonica Inhibit Papain-Like Protease of Severe Acute Respiratory Syndrome Coronavirus
- (2012) Ji-Young Park et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
- (2012) Ji-Young Park et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Kaempferol regulates MAPKs and NF-κB signaling pathways to attenuate LPS-induced acute lung injury in mice
- (2012) Xiaojun Chen et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Obesity and the risk and outcome of infection
- (2012) R Huttunen et al. INTERNATIONAL JOURNAL OF OBESITY
- Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist
- (2011) Roelie M Wösten-van Asperen et al. JOURNAL OF PATHOLOGY
- Glycyrrhizin inhibits highly pathogenic H5N1 influenza A virus-induced pro-inflammatory cytokine and chemokine expression in human macrophages
- (2010) Martin Michaelis et al. MEDICAL MICROBIOLOGY AND IMMUNOLOGY
- Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes
- (2009) Jin-Kui Yang et al. ACTA DIABETOLOGICA
- The spike protein of SARS-CoV — a target for vaccine and therapeutic development
- (2009) Lanying Du et al. NATURE REVIEWS MICROBIOLOGY
- Immunoparalysis and Adverse Outcomes from Critical Illness
- (2008) W. Joshua Frazier et al. PEDIATRIC CLINICS OF NORTH AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search